Home / Octreotide / Austria
AT ATC H01CB02 · updated 2 Nov 2026
Octreotide shortage in Austria
Is there an Octreotide shortage in Austria?
Yes. As of 2 Nov 2026, 1 Octreotide product is reported short in Austria, the first since 8 Oct 2026. The company estimate for the return is 23 Nov 2026. Main reason: distribution or logistics.
Also short in Canada, Italy, Spain, Sweden, Japan. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Sandostatin 50 Mikrogramm/ml Injektions-/Infusionslösung, 5 Stück limited | Novartis Pharma GmbH | 8 Oct 2026 | 23 Nov 2026 | Distribution or logistics Verzögerung bei der Auslieferung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).